VanEck Associates’s Community Healthcare Trust CHCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,106
Closed -$96K 1384
2024
Q2
$96K Buy
4,106
+279
+7% +$6.78K ﹤0.01% 1254
2024
Q1
$102K Buy
3,827
+87
+2% +$2.29K ﹤0.01% 1233
2023
Q4
$100K Buy
3,740
+751
+25% +$20.7K ﹤0.01% 1240
2023
Q3
$89K Buy
2,989
+124
+4% +$4.16K ﹤0.01% 1239
2023
Q2
$95K Buy
2,865
+272
+10% +$9.46K ﹤0.01% 1245
2023
Q1
$95K Buy
2,593
+134
+5% +$5.23K ﹤0.01% 1244
2022
Q4
$88K Buy
2,459
+1,092
+80% +$37.2K ﹤0.01% 1271
2022
Q3
$45K Sell
1,367
-784
-36% -$29K ﹤0.01% 1271
2022
Q2
$78K Buy
2,151
+12
+0.6% +$450 ﹤0.01% 1255
2022
Q1
$90K Buy
2,139
+280
+15% +$12.1K ﹤0.01% 1245
2021
Q4
$88K Buy
1,859
+758
+69% +$34.8K ﹤0.01% 1264
2021
Q3
$50K Buy
1,101
+160
+17% +$7.76K ﹤0.01% 1237
2021
Q2
$45K Buy
941
+14
+2% +$685 ﹤0.01% 1211
2021
Q1
$43K Buy
927
+32
+4% +$1.49K ﹤0.01% 1093
2020
Q4
$42K Buy
895
+243
+37% +$11.6K ﹤0.01% 974
2020
Q3
$30K Buy
652
+137
+27% +$6.27K ﹤0.01% 972
2020
Q2
$21K Buy
+515
New +$19.3K ﹤0.01% 967

Other funds holding CHCT

VanEck Associates's CHCT Position: Q3 2024 in Review

VanEck Associates sold out of Community Healthcare Trust (CHCT) in Q3 2024, closing a stake of 4,106 shares — an estimated $96K sold.

VanEck Associates first reported a position in CHCT in Q2 2020 and held it in 17 quarters. The position peaked at $102K in Q1 2024. 183 funds tracked by Wall St. Rank hold CHCT as of Q3 2024.

  • VanEck Associates reported no remaining Community Healthcare Trust position as of Q3 2024 after selling out during the quarter.
  • VanEck Associates sold 4,106 Community Healthcare Trust shares in Q3 2024, an estimated $96K.
  • VanEck Associates first reported a position in Community Healthcare Trust in Q2 2020 and held it in 17 quarters.
  • VanEck Associates's Community Healthcare Trust position peaked at $102K in Q1 2024.
  • 183 funds tracked by Wall St. Rank held Community Healthcare Trust as of Q3 2024.

Based on VanEck Associates's 13F filing for Q3 2024, filed 29 Oct 2024.